[1] Ferguson CM, Swaroop MN, Horick N, et al. Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer[J]. J Clin Oncol,2016,34(7):691-698. [2] Lopez AM, Pruthi S, Boughey JC, et al. Double-blind, randomized trial of alternative letrozole dosing regimens in postmenopausal women with increased breast cancer risk[J]. Cancer Prev Res (Phila),2016,9(2):142-148. [3] 郭旭辉,李军涛,秦丽,等. 原癌基因MYC在乳腺癌中的表达及与预后关系[J]. 中华实用诊断与治疗杂志,2018,32(6):583-585. [4] 魏昕,杨举伦. 乳腺癌组织中ERCC1、Ki67、PCNA表达与蒽环类化疗药物敏感性的关系[J]. 中国免疫学杂志,2015,31(2):169-172. [5] 杨庄青,李梅,王建逵,等. 三阴性乳腺癌中c-myc蛋白的表达及其与术后复发转移的关系[J]. 中国老年学杂志,2017,37(15):3789-3791. [6] 刘西林,张永生,韩洁,等. PHH3和Ki-67在乳腺浸润性导管癌组织中的表达及其临床意义[J]. 临床与实验病理学杂志,2015,31(11):1228-1232. [7] 陈青,吴克瑾. Ki-67乳腺癌临床应用价值及其临界值界定的研究进展[J]. 中华外科杂志,2015,53(8):634-637. [8] 于秀文,李春燕,李春旭. 乳腺癌TopoⅡα、C-MYC基因检测与Ki-67表达的研究[J]. 中国妇幼保健,2015,30(24):4210-4213.
2019, Vol. 36 
